Emerging Jobs in Life Sciences and What You Should Be Training for Now
|出版日期||內容資訊||英文 15 Pages
|生命科學的新領域與現在應接受的訓練 Emerging Jobs in Life Sciences and What You Should Be Training for Now|
|出版日期: 2019年02月28日||內容資訊: 英文 15 Pages||
NGS (次世代定序) 應用市場，預計2016年達27億美元，至2022年擴大到105億美元。
本報告提供生命科學/生物科技產業上有潛力職業課程的新興趨勢/成長趨勢的相關調查，CRISPR技術的理解在職業開發中成為重要技術的理由，基因學資料管理相關資訊與專攻基因學、遺傳基因的學生來說的職業創造的作用，奈米技術用途的考察與生物醫學工程工作中，那些的作用評估，對人工智能 (AI) 、藥物研發相關的職業，生物科技/醫藥品專家而言的潛在職業課程等資訊。
To develop and more importantly to improve current technologies, the market needs a pipeline of talent: well-educated and skilled scientists. Today, a new graduate or scientist with an immunology background will have a strong advantage in the market.
The market for NGS applications reached $2.7 billion in 2016 and is expected to expand to $10.5 billion by 2022.
The expanding biotech market offers a variety of careers. In some cases, we need to be creative and see behind the obvious scientific path.
Finding the right career path is one of the biggest challenges in every person's life. We want to make sure we make the right choices and decisions concerning our future employment opportunities. And it's no longer a one-time decision. Employment conditions and opportunities are not constantly evolving and this requires us to update our skill set and knowledge base on a continual basis.
This analysis of current and emerging trends in the market can be helpful in making the right decision based on your personality, education and other skills. In our dynamic and constantly evolving world, in order to succeed, a person needs to understand what potential future directions the job market might take and how novel technologies will affect the need to change one's career track or train for a new career path.
Trends described below will help readers navigate the evolving biotech market to choose the right direction.
It is obvious that the immune approach to treat cancer or so-called cancer immunotherapy has become "the next big thing." Recent drug development trends show that immunotherapy can be more effective and efficient than traditional chemotherapies.
Cancer immunotherapy/immuno-oncology is defined as artificial stimulation of the immune system to treat cancer, thus improving one's natural ability to fight this disease. This approach exploits the fact that cancer cells have specific tumor antigens that can be detected by the antibody proteins of the immune system. Normal antibodies bind to external pathogens; however, modified immunotherapy antibodies bind to the tumor antigens. This helps the immune system to inhibit or kill cancer cells.